Title : Metformin sensitizes EGFR-TKI-resistant human lung cancer cells in vitro and in vivo through inhibition of IL-6 signaling and EMT reversal.

Pub. Date : 2014 May 15

PMID : 24644001






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Metformin sensitizes EGFR-TKI-resistant human lung cancer cells in vitro and in vivo through inhibition of IL-6 signaling and EMT reversal. Metformin epidermal growth factor receptor Homo sapiens
2 This study aims to investigate the effect of metformin on sensitizing EGFR-TKI-resistant human lung cancer cells in vitro and in vivo through inhibition of IL-6 signaling and EMT reversal. Metformin epidermal growth factor receptor Homo sapiens
3 CONCLUSION: Metformin, generally considered nontoxic and remarkably inexpensive, might be used in combination with TKIs in patients with non-small cell lung cancer, harboring EGFR mutations to overcome TKI resistance and prolong survival. Metformin epidermal growth factor receptor Homo sapiens